Interferon beta in the cytokine network: an anti-inflammatory pathway

A Billiau1

  • 1Rega Institute, University of Leuven, Faculty of Medicine, Belgium.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 1, 1995
PubMed

Insights

Interferon beta (IFN-beta), a type I interferon, is a cytokine that can be produced by many cells. It acts as an inflammation inhibitor by deactivating mononuclear phagocytes, which is relevant for multiple sclerosis treatment.

Area of Science:

  • Immunology
  • Cellular Biology
  • Cytokine Signaling

Background:

  • Interferons (IFNs) are crucial cytokines mediating intercellular communication.
  • Type I interferons, including IFN-beta, possess distinct structural and functional characteristics compared to Type II interferon (IFN-gamma).
  • IFN-beta exhibits broader cellular production and diverse functional interactions with other cytokines, unlike the lymphokine IFN-gamma.

Purpose of the Study:

  • To elucidate the role of IFN-beta in cellular communication and immune responses.
  • To highlight the unique properties of IFN-beta within the interferon family.
  • To investigate the potential therapeutic relevance of IFN-beta's anti-inflammatory functions, particularly in the context of multiple sclerosis.

Main Methods:

  • Comparative analysis of Type I and Type II interferon properties.
  • Investigation of IFN-beta's induction by and interaction with other cytokines (e.g., interleukin I).
  • Exploration of IFN-beta's effects on cellular signaling pathways and transcription activation.
  • Assessment of IFN-beta's capacity to modulate mononuclear phagocyte activity.

Main Results:

  • IFN-beta is a versatile cytokine produced by various cell types, differentiating it from the lymphocyte-specific IFN-gamma.
  • IFN-beta's activity is modulated by other cytokines, influencing signal transduction and gene expression.
  • IFN-beta demonstrates a significant role in deactivating mononuclear phagocytes.
  • This deactivating function positions IFN-beta as a potential inhibitor of inflammatory processes.

Conclusions:

  • IFN-beta is a key type I interferon with broad cellular origins and regulatory interactions.
  • Its ability to deactivate mononuclear phagocytes suggests a critical anti-inflammatory role.
  • The anti-inflammatory properties of IFN-beta hold significant therapeutic potential for inflammatory diseases like multiple sclerosis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...